Literature DB >> 7883949

Effect of alpha-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis.

A M Lafont1, Y C Chai, J F Cornhill, P L Whitlow, P H Howe, G M Chisolm.   

Abstract

The ability of alpha-tocopherol to reduce restenosis after angioplasty was tested in a rabbit model in which angioplasty was performed on established atherosclerotic lesions. Lesions induced by 4 wk of cholesterol feeding after focal desiccation of femoral arteries were balloon dilated. 3 wk after angioplasty, angiographically determined minimum luminal diameters were less in the untreated group (0.80 +/- 0.51 mm) than in the group treated with oral alpha-tocopherol beginning 19 d before angioplasty (1.38 +/- 0.29 mm; P < 0.01). The cross-sectional area of the intima-media was greater in the untreated group (1.18 +/- 0.48 mm2) than in the alpha-tocopherol group (0.62 +/- 0.25 mm2, P < 0.0001). These differences were not due to vasoconstriction or altered plasma cholesterol. Alpha-tocopherol thus reduced restenosis after angioplasty in this model. In rabbit vascular smooth muscle cells, oxidized low density lipoprotein stimulated DNA synthesis. Alpha-tocopherol treatment inhibited DNA synthesis stimulated by oxidized low density lipoprotein, but not by serum. The findings are consistent with the hypothesis that oxidized lipids can stimulate hyperplasia and that antioxidants may limit hyperplasia by inhibiting either the oxidation or the proliferative effects of oxidants on cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7883949      PMCID: PMC441435          DOI: 10.1172/JCI117746

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

Review 1.  Role of oxidatively modified LDL in atherosclerosis.

Authors:  U P Steinbrecher; H F Zhang; M Lougheed
Journal:  Free Radic Biol Med       Date:  1990       Impact factor: 7.376

Review 2.  Role of oxidized human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation.

Authors:  S Chatterjee
Journal:  Mol Cell Biochem       Date:  1992-04       Impact factor: 3.396

3.  Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C.

Authors:  D Boscoboinik; A Szewczyk; C Hensey; A Azzi
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

4.  Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA).

Authors:  S J DeMaio; S B King; N J Lembo; G S Roubin; J A Hearn; H N Bhagavan; D S Sgoutas
Journal:  J Am Coll Nutr       Date:  1992-02       Impact factor: 3.169

5.  Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression.

Authors:  G N Rao; B C Berk
Journal:  Circ Res       Date:  1992-03       Impact factor: 17.367

6.  The influence of oxidatively modified low density lipoproteins on expression of platelet-derived growth factor by human monocyte-derived macrophages.

Authors:  L T Malden; A Chait; E W Raines; R Ross
Journal:  J Biol Chem       Date:  1991-07-25       Impact factor: 5.157

7.  Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits.

Authors:  I J Sarembock; S D Gertz; L W Gimple; R M Owen; E R Powers; W C Roberts
Journal:  Circulation       Date:  1991-07       Impact factor: 29.690

8.  Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells.

Authors:  M Jougasaki; K Kugiyama; Y Saito; K Nakao; H Imura; H Yasue
Journal:  Circ Res       Date:  1992-09       Impact factor: 17.367

9.  Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium.

Authors:  C M Boulanger; F C Tanner; M L Béa; A W Hahn; A Werner; T F Lüscher
Journal:  Circ Res       Date:  1992-06       Impact factor: 17.367

10.  Inhibition of lipopolysaccharide-induced interleukin-1 beta mRNA expression in mouse macrophages by oxidized low density lipoprotein.

Authors:  L G Fong; T A Fong; A D Cooper
Journal:  J Lipid Res       Date:  1991-12       Impact factor: 5.922

View more
  7 in total

Review 1.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

2.  Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor.

Authors:  C H MacPhee; K E Moores; H F Boyd; D Dhanak; R J Ife; C A Leach; D S Leake; K J Milliner; R A Patterson; K E Suckling; D G Tew; D M Hickey
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

3.  Impaired graft healing due to hypercholesterolemia is prevented by dietary supplementation with alpha-tocopherol.

Authors:  Keiko Miyazaki; Scott M Colles; Linda M Graham
Journal:  J Vasc Surg       Date:  2008-06-30       Impact factor: 4.268

Review 4.  Oxidant stress in the vasculature.

Authors:  M Maytin; J Leopold; J Loscalzo
Journal:  Curr Atheroscler Rep       Date:  1999-09       Impact factor: 5.967

5.  Saffron supplements modulate serum pro-oxidant-antioxidant balance in patients with metabolic syndrome: A randomized, placebo-controlled clinical trial.

Authors:  Tayyebeh Kermani; Seyyed Hadi Mousavi; Maryam Shemshian; Abdolreza Norouzy; Mohsen Mazidi; Atefeh Moezzi; Toktam Moghiman; Majid Ghayour-Mobarhan; Gordon A Ferns
Journal:  Avicenna J Phytomed       Date:  2015 Sep-Oct

Review 6.  Oxidative stress, alpha-tocopherol therapy, and atherosclerosis.

Authors:  Andrea Harris; Sridevi Devaraj; Ishwarlal Jialal
Journal:  Curr Atheroscler Rep       Date:  2002-09       Impact factor: 5.967

7.  Bo-Gan-Whan regulates proliferation and migration of vascular smooth muscle cells.

Authors:  Kang Pa Lee; Jai-Eun Kim; Hyuck Kim; Hae Ryong Chang; Dae Won Lee; Won-Hwan Park
Journal:  BMC Complement Altern Med       Date:  2016-08-22       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.